What is Polaryx Therapeutics, Inc. 's deferred tax liabilities?

Polaryx Therapeutics, Inc. (PLYX) reported deferred tax liabilities of $250K in Q4 2025.

What does deferred tax liabilities mean?

Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.

Polaryx Therapeutics, Inc. PLYX Deferred Tax Liabilities

Deferred Tax Liabilities at other companies

BJ's Wholesale Club Holdings, Inc.BJ

$68.23M+23.2%

Carpenter TechnologyCRS

$176.4M+7.6%

InvescoIVZ

$942.4M-29.1%

Element SolutionsESI

$93.1M-0.9%

Merck & Co.MRK

$338M-8.9%

Expeditors International of WashingtonEXPD

$2.48M—

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$115.64M—

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesOther.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's deferred tax liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's deferred tax liabilities?: Polaryx Therapeutics, Inc. (PLYX) reported deferred tax liabilities of $250K in Q4 2025.
What does deferred tax liabilities mean?: Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.